Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Dr. Kang Sun [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 29, 2026, Dr. Kang Sun, our Executive Advisor and a member of our Board of Directors, terminated the trading plan he adopted on August 18, 2025 that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a "Rule 10b5-1 Plan"). Dr. Sun's Rule 10b5-1 Plan provided for the potential sale of up to 7,217,869 shares of our common stock and, prior to its termination, was scheduled to expire on December 31, 2026.
|
| Name | Dr. Kang Sun |
| Title | Executive Advisor and a member of our Board of Directors |
| Rule 10b5-1 Arrangement Terminated | true |
| Termination Date | June 29, 2026 |
| Aggregate Available | 7,217,869 |
| Dr. Steven Chu [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 10, 2026, Dr. Steven Chu, a member of our Board of Directors, adopted a Rule 10b5-1 Plan providing for the potential sale of up to 388,057 shares of our common stock. Dr. Chu's Rule 10b5-1 Plan expires on March 13, 2027. |
| Name | Dr. Steven Chu |
| Title | member of our Board of Directors |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 10, 2026 |
| Expiration Date | March 13, 2027 |
| Arrangement Duration | 276 days |
| Aggregate Available | 388,057 |